Associated Papers
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.
Foyzun T et al.
British Journal of Pharmacology, 2024
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy.
Yin G et al.
Genome Medicine, 2024
38217005 (PubMed )
Supplement: 13073_2024_1286_MOESM2_ESM.xlsx › Table_S4
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado ÁF et al.
Cell Reports. Medicine, 2023
36652909 (PubMed )
Supplement: mmc3.xlsx › BrM167
Whole genome mapping and identification of single nucleotide polymorphisms of four Bangladeshi individuals and their functional significance.
Khan S et al.
Bmc Research Notes, 2021
33743798 (PubMed )
Supplement: 13104_2021_5514_MOESM4_ESM.zip › Supplementary_File_1A-1.xlsx › Supplementary_File_1A-1.exonic_
The role of GPCRs in bone diseases and dysfunctions.
Luo J et al.
Bone Research, 2019
X-linked ADGRG2 mutation and obstructive azoospermia in a large Pakistani family.
Khan MJ et al.
Scientific Reports, 2018
30389958 (PubMed )
Supplement: 41598_2018_34262_MOESM2_ESM.xlsx › 1._nonsynonymous_variants
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.
Wasilewski A et al.
The American Journal of Gastroenterology, 2017
Phenotypic screening of cannabinoid receptor 2 ligands shows different sensitivity to genotype.
Hillger JM et al.
Biochemical Pharmacology, 2017
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Scott RA et al.
Science Translational Medicine, 2016
Evaluation of Hybridization Capture Versus Amplicon-Based Methods for Whole-Exome Sequencing.
Samorodnitsky E et al.
Human Mutation, 2015
26110913 (PubMed )
Supplement: HUMU-36-903-s001.zip › humu22825-sup-00010-Table_S13.xlsx › Sheet1
Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases.
Vasileiou I et al.
Expert Opinion on Therapeutic Targets, 2013
Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor.
Carrasquer A et al.
Pharmacogenetics and Genomics, 2010
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.
Liu QR et al.
Genes, Brain, and Behavior, 2009
Cannabinoid receptor type 2 gene is associated with human osteoporosis.
Karsak M et al.
Human Molecular Genetics, 2005
Select a paper to view details